Galvin M, Hill C, Ross R P
National Food Biotechnology Centre, University College Cork, Ireland.
Lett Appl Microbiol. 1999 May;28(5):355-8. doi: 10.1046/j.1365-2672.1999.00550.x.
Lacticin 3147 is a broad-spectrum bacteriocin produced by Lactococcus lactis subsp. lactis DPC3147, which has been shown to be active against a range of food-borne bacteria. The reported inhibitory range for lacticin is extended to include methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, penicillin-resistant Pneumococcus, Propionibacterium acne and Streptococcus mutans. This extended host range is not obvious from traditional agar plate-based methods, but reductions in bacterial cell numbers by up to 6 log10 cfu ml-1 was observed after 2 h in time-kill curve studies conducted in broth, suggesting that the bacteriocin may have potential as a therapeutic agent in the treatment of human infections.
乳酸链球菌素3147是由乳酸乳球菌乳酸亚种DPC3147产生的一种广谱细菌素,已证明其对多种食源细菌具有活性。据报道,乳酸链球菌素的抑制范围扩大到包括耐甲氧西林金黄色葡萄球菌、耐万古霉素粪肠球菌、耐青霉素肺炎球菌、痤疮丙酸杆菌和变形链球菌。从传统的基于琼脂平板的方法中,这种扩大的宿主范围并不明显,但在肉汤中进行的时间-杀菌曲线研究中,2小时后观察到细菌细胞数量减少高达6 log10 cfu ml-1,这表明该细菌素可能具有作为治疗人类感染的治疗剂的潜力。